Fda Places Full Clinical Hold on Biomea Fusion's Diabetes Trials Of Bmf 219


The US FDA has placed a full clinical hold on Biomea Fusion's Phase I/II clinical trials assessing BMF-219 for type 1
Clinical Trials Arena 11:44 am on June 7, 2024



https://www.clinicaltrialsarena.com/news/fda-hold-biomea-trials/

< Previous Story     -     Next Story >

Copy and Copyright Pubcon Inc.
1996-2024 all rights reserved. Privacy Policy.
All trademarks and copyrights held by respective owners.